Inventor · disambiguated record
Harri Salo
Also filed as: SALO HARRI · SALO HARRI ELIAS
10 granted patents·3 pending applications·59 citations·filing 2001–2020
88Inventor score
Top patents by PatentIndex Score
13 records- 0191US11046713B2Androgen receptor modulating compoundsORION CORP·Filed 2020·Granted Jun 29, 2021·2 cites·2 claims
- 0291US10711013B2Androgen receptor modulating compoundsORION CORP·Filed 2018·Granted Jul 14, 2020·2 cites·17 claims
- 0390US10118933B2Androgen receptor modulating compoundsORION CORP·Filed 2017·Granted Nov 6, 2018·8 cites·3 claims
- 0485US8921378B2Androgen receptor modulating carboxamidesTÖRMÄKANGAS OLLI·Filed 2012·Granted Dec 30, 2014·16 cites·12 claims
- 0581US9657003B2Androgen receptor modulating compoundsORION CORP·Filed 2015·Granted May 23, 2017·3 cites·10 claims
- 0680US8975254B2Androgen receptor modulating compoundsWOHLFAHRT GERD·Filed 2010·Granted Mar 10, 2015·8 cites·8 claims
- 0771US6593324B2Dervatives of quinoline as alpha-2 antagonistsORION CORP·Filed 2001·Granted Jul 15, 2003·5 cites·15 claims
- 0865US9533952B2N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonistsORION CORP·Filed 2013·Granted Jan 3, 2017·2 cites·17 claims
- 0962US6767909B2Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptorJUVANTIA PHARMA LTD OY·Filed 2002·Granted Jul 27, 2004·6 cites·21 claims
- 1061US7741362B2Somatostatin receptor 1 and/or 4 selective agonists and antagonistsSIEGFRIED WURSTER·Filed 2004·Granted Jun 22, 2010·7 cites·13 claims
- 1153US2003225078A1Derivatives of quinoline as alpha-2 antagonistsORION CORP·Filed 2003·Application pending·0 cites
- 1243US2010004339A1Somatostatin Receptor 1 and/or 4 Selective Agonists and AntagonistsJUVANTIA PHARMA LTD OY·Filed 2009·Application pending·0 cites
- 1331US2010048549A1Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4TOMPERI JUSSI·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →